The Growth Channel

The latest innovations in market strategy and share competition

Not all drugs are created equal—so why should prices be?

by Allison Harvey February 4, 2016

Cancer drug costs are rising at an alarming rate, even when compared to other health care spending. Medical expenditures in the U.S. for cancer are expected to rise 27% between 2010 and 2020 to a total of at least $158 billion. Lowering the astronomical cost of cancer care is an urgent priority for cancer programs across the country.

So why have few value-based cancer care models targeted the pharmaceutical industry?

Because CMS cannot negotiate prices with drug companies (and many commercial payers follow CMS’s methodology), they have avoided price regulation. Most value-based models in cancer care now are centered on bundled payments or ACOs, which incent providers to improve overall cohesiveness of care and reduce unnecessary spending. While these programs sometimes include drugs, they do not specifically address drug costs or incentivize pharmaceutical companies’ involvement in patient outcomes.

Read more »

Want to be a Super Planner? You'll need scenario planning powers.

by Caitlin Gillooley February 3, 2016

You’re great at your job, but you’re not a superhero (unfortunately, the concept of Super Planner never took off with comic book writers). So why does your boss or your board expect you to know exactly where the market will go in the next 5 to 10 years?

All hospitals and health systems work on near-term analytics—for example, looking at expected inpatient volumes for next year; most organizations engage in vision-setting for what health care will look like in 20 years. But only the most progressive providers can plan for the next five years, which gives them a huge advantage in our current, volatile market.

It’s not easy to wade through all of the millions of potential future states and calculate the probability and impact each might have on your revenue; it’s also not worth your time. So when you’re asked to flex your psychic muscles, here’s where to start.

Read more »

The role ASCs should play in your value-based care strategy

Stephen Faro , Anthony D'Eredita, JD, MSL, MBA January 26, 2016

In our consulting work, we often help health systems design and execute an ambulatory network strategy. As payers push toward value-based and site-neutral reimbursement models, we’ve noticed our health system clients are asking more questions about the role ASCs should play in their broader ambulatory strategy—and they’re right to shift strategic focus toward ASCs.

Read more »

Which CV sub-service line should you invest in?

by Ameay Naravane and Jason Glaw January 22, 2016

With the ongoing changes in care offerings, payment models, and hospital and physician partnerships in the cardiovascular service line, strategic planners have an increasingly important role in determining how to prioritize resources among sub-service lines.

Here are five variables hospital leaders should weigh as they invest time and capital, along with our recommendations for the sub-service lines we project to have the largest impact on each variable in the near term.

Read more »

Telehealth policy moves to watch in 2016

by Caitlin Gillooley January 21, 2016

Interest, investment, and utilization of telehealth have been steadily growing across the past few years, but the status quo is still the old-fashioned in-person clinical encounter. What’s holding the market back from widely embracing virtual care?

As we’ve discussed before, a major barrier to the spread of telehealth is policy—particularly regarding reimbursement and practice standards. But based on the buzz, we predict that we’ll finally see this barrier fall in 2016. Here are the policy shifts to watch for across the next few months.

Read more »

Outcomes tracking isn't just for care quality—it's good for referrals too

by Sarah Izzo January 15, 2016

As new payment mechanisms compel providers to focus on the full continuum of care, establishing protocols to document, track, and analyze patient outcomes has become a "must-have." For those providers with robust outcomes tracking, our research has shown us they most typically use it to measure hospital performance and improve care quality. But we’ve identified other compelling uses for outcomes data.

Bolstering marketing efforts to increase patient volumes comes first to mind. Specifically, sharing patient outcomes data with referring physicians and patients in the community helps hospitals demonstrate high-quality care.

Read on to learn about three ways outcomes tracking and data sharing can help you capture market share.

Read more »

Four trends shaping bariatric program growth in 2016

by Zack Panos January 13, 2016

Our team recently attended Obesity Week 2015, which brings together top experts in bariatrics and reviews trends in obesity services. We identified four trends strategic planners need to keep an eye on to grow their bariatric programs in 2016.

Read more »

3 issues on ambulatory growth to watch in 2016

by Sarah Musco, Caitlin Gillooley, and Emily Zuehlke January 8, 2016

The health care industry will be grappling with more than getting used to writing 2016 on checks this year. 2015 was filled with challenges like insurance exchanges, virtual care, and price transparency—and those issues aren’t going away. We’ve identified three more subjects our members should watch this year.

Read more »

  • Manage your events
  • View your saved items
  • Manage your subscriptions
  • Update personal information
  • Invite a colleague